Medication Safety 2.0: Advances in Adherence Technology

A recently published review on emerging smart technology innovations in the health care sector suggests various advanced technologies and methods may now significantly improve medication adherence.1 Two significant advances have been the ability to measure medication adherence and safety issues with medication event monitoring systems (MEMS) and smart blister packs containing radio frequency identification technology.

Hey Founder, Here’s How To Build Your Brand

Building and establishing your personal brand is key to standing out in the current market. Your brand is your track record plus reputation—everything that people currently know you for. Here are four tangible steps to make yourself and your company stand out!

Lacerta Therapeutics Expands Executive Leadership Team

UF startup Lacerta Therapeutics, a preclinical-stage gene therapy company, announces an expansion in the executive leadership team: illustrating Lacerta’s commitment to developing a constellation of gene-based therapies.

Capri EGM Build-to-Suit Program Acquires Life Science Real Estate Asset for Company Manufacturing Antibodies for Department of Defense and mRNA for COVID-19 Vaccine

UF startup Ology Bioservices, a wholly owned subsidiary of Resilience, and the operator of the Lab & Research facility, has recently been awarded contract valued as much as $250 million by the Department of Defense for manufacturing development of a monoclonal antibody as a medical countermeasure (MCM) to botulinum neurotoxins (BoNT).